0001209191-22-036347.txt : 20220613
0001209191-22-036347.hdr.sgml : 20220613
20220613164112
ACCESSION NUMBER: 0001209191-22-036347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 221012178
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-09
0
0001434316
FATE THERAPEUTICS INC
FATE
0001274139
HERSHBERG ROBERT
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
1
0
0
0
Common Stock
2022-06-09
4
A
0
8650
0.00
A
10659
D
Stock Option (Right to Buy)
23.48
2022-06-09
4
A
0
11893
0.00
A
2032-06-09
Common Stock
11893
11893
D
Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
/s/ Cindy Tahl, as Attorney-in-Fact
2022-06-13